Royal Philips (NYSE:PHG) said today that its board of directors is backing the re-appointment of Frans van Houten as its president and CEO and Abhijit Bhattacharya as chief financial officer and board member. CEO van Houten has been at the head of Philips since 2011, while Bhattacharya joined the company in 2015, Amsterdam-based Philips said. During […]
Shares in Harvard Biosciences (NSDQ:HBIO) fell today after the medtech company met expectations on Wall Street with its third quarter earnings results, but dropped its guidance for the full year. The Holliston, Mass.-based company posted losses of $256,000, or 1¢ per share, on sales of $28.6 million for the three months ended September 30, seeing […]
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.
Massachusetts scientific instrument maker Harvard Bioscience named Jeffrey Duchemin its new CEO, who took over the company in the midst of the spinout of its regenerative therapies unit.
ConforMIS lured Zimmer’s dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.
The Bedford, Mass.-based medical device company said Scott bring’s a decade’s worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients’ morphology.
Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there.
Christopher Lyles, the 1st U.S. patient and the 2nd worldwide to receive a stem cell trachea transplant, died this month of unknown causes.
Lyles received an experimental trachea grown from his own stem cells and cultivated in a bioreactor made by Harvard Bioscience (NSDQ:HBIO) in November 2011.